BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22319442)

  • 1. Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.
    Viejo-Borbolla A; Martinez-Martín N; Nel HJ; Rueda P; Martín R; Blanco S; Arenzana-Seisdedos F; Thelen M; Fallon PG; Alcamí A
    PLoS Pathog; 2012 Feb; 8(2):e1002497. PubMed ID: 22319442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus particles interact with chemokines and enhance cell migration.
    Martínez-Martín N; Viejo-Borbolla A; Alcami A
    J Gen Virol; 2016 Nov; 97(11):3007-3016. PubMed ID: 27692045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection.
    Cabrera JR; Viejo-Borbolla A; Martinez-Martín N; Blanco S; Wandosell F; Alcamí A
    PLoS Pathog; 2015 Jan; 11(1):e1004571. PubMed ID: 25611061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization.
    Martinez-Martin N; Viejo-Borbolla A; Martín R; Blanco S; Benovic JL; Thelen M; Alcamí A
    Nat Commun; 2015 Jan; 6():6163. PubMed ID: 25625471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.
    Rao P; Wen X; Lo JH; Kim S; Li X; Chen S; Feng X; Akbari O; Yuan W
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
    Gerber SI; Belval BJ; Herold BC
    Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN.
    de Jong MAWP; de Witte L; Bolmstedt A; van Kooyk Y; Geijtenbeek TBH
    J Gen Virol; 2008 Oct; 89(Pt 10):2398-2409. PubMed ID: 18796707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid substitutions in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus types 1 and 2 but not for Pseudorabies virus or bovine herpesvirus 1.
    Martinez WM; Spear PG
    J Virol; 2002 Jul; 76(14):7255-62. PubMed ID: 12072525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B.
    Dyer AP; Banfield BW; Martindale D; Spannier DM; Tufaro F
    J Virol; 1997 Jan; 71(1):191-8. PubMed ID: 8985338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0.
    Melchjorsen J; Pedersen FS; Mogensen SC; Paludan SR
    J Virol; 2002 Mar; 76(6):2780-8. PubMed ID: 11861845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.
    Rasmussen SB; Sørensen LN; Malmgaard L; Ank N; Baines JD; Chen ZJ; Paludan SR
    J Virol; 2007 Dec; 81(24):13315-24. PubMed ID: 17913820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.
    Brans R; Akhrameyeva NV; Yao F
    J Invest Dermatol; 2009 Oct; 129(10):2470-9. PubMed ID: 19357711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
    Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera.
    Fujima A; Ochiai Y; Saito A; Omori Y; Noda A; Kazuyama Y; Shoji H; Tanabayashi K; Ueda F; Yoshikawa Y; Hondo R
    J Clin Microbiol; 2008 Jan; 46(1):56-61. PubMed ID: 17989200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane.
    Fontana J; Atanasiu D; Saw WT; Gallagher JR; Cox RG; Whitbeck JC; Brown LM; Eisenberg RJ; Cohen GH
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T; Gianopulos KA; Nicola AV
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Characterization of Glycoprotein H Chimeras Composed of Conserved Domains of the Pseudorabies Virus and Herpes Simplex Virus 1 Homologs.
    Böhm SW; Backovic M; Klupp BG; Rey FA; Mettenleiter TC; Fuchs W
    J Virol; 2016 Jan; 90(1):421-32. PubMed ID: 26491153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2.
    Kropp KA; Srivaratharajan S; Ritter B; Yu P; Krooss S; Polten F; Pich A; Alcami A; Viejo-Borbolla A
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.